Scope In January 2021, the ESCMID Executive Committee decided to launch a new initiative
to develop ESCMID guidelines on several COVID-19-related issues, including treatment of …

Evaluating trends in antibiotic resistance is a requisite. The study aimed to analyze the profile
of multidrug-resistant organisms (MDROs) among hospitalized patients with bacteremia in …

Scope Despite the large availability of vaccines, coronavirus disease 2019 (COVID-19),
induced by severe acute respiratory syndrome coronavirus 2, continues to be a major threat for …

Fever of unknown origin (FUO) is a serious challenge for physicians. The aim of the present
study was to consider epidemiology and dynamics of FUO in countries with different …

Introduction Data suggests that invasive fungal infections (IFI) might complicate COVID-19.
Our goal was to describe characteristics of IFI among critically ill COVID-19 adults. Methods A …

Objectives Our aim was to compare outcomes of hospitalized adults with severe COVID-19
and cytokine storm treated with tocilizumab or baricitinib. Methods A prospective, …

We explored the self-reported antibiotic stewardship (AS), and infection prevention and
control (IPC) activities in intensive care units (ICUs) of different income settings. A cross-sectional …

Large randomized clinical trials in severe Coronavirus Disease 2019 (COVID-19) patients
have proven efficacy of intravenous tocilizumab. Our aim was to describe the laboratory …

There is an ongoing debate worldwide about the possible benefits of ivermectin for the treatment
and prevention of COVID-19. Some advocacy groups have concluded, based on limited…

Background: Characteristics of the blood microbiota among adult patients with community-acquired
sepsis are poorly understood. Our aim was to analyse the composition of blood …